References
- Liebowitz MR, Schneier F, Campeas R. Phenelzine versus atenolol in social phobia: a placebo-con- trolled comparison. Arch Gen Psychiatr 1992;49:290–300.
- Davidson JTR, Potts N, Richichi E, Krishnan R, Ford SM, Wilson WH. Treatment of social phobia with clonazepam and placebo. J Clin Psychophar-macol 1993;13:423–8.
- Versiani M, Nardi AE, Mundim FD, Alves AB, Liebowitz MR, Amrein R. Pharmacotherapy of social phobia: a controlled study with moclobe-mide and phenelzine. Br J Psychiatr 1992;161:353– 60.
- Versiani M, Mundim FD, Nardi AE, Liebowitz MR. Tranylcypromine in social phobia. J Clin Psy-chopharmacol 1988;8:279–83.
- Lydiard RB, Laraia MT, Howell EF, Ballenger JC. Alprazolam in the treatment of social phobia. J Clin Psychiatr 1988;49:17–9.
- Schneier FR, Saoud JB, Campeas R. Buspirone in social phobia. J Clin Psychopharmacol 1993;13:251–6.
- Berk M. Fluoxetine and social phobia. J Clin Psy-chiatr 1995;56:36–7.
- Katzelnick DJ, Kobak KA, Greist JH. Sertraline in social phobia: a double-blind, placebo-controlled crossover study. Am J Psychiatr 1995;152:1368–71.
- Mancini C, Van Ameringen M. Paroxetine in social phobia. J Clin Psychiatr 1996;57:519–22.
- Van Vliet LM, Den Boer J, Westenberg HGM. Psychopharmacological treatment of social phobia: a double-blind placebo controlled study with fluvoxamine. Psychopharmacology 1994;115:128– 34.
- Lepola U, Koponen H, Leinonen E. Citalopram in the treatment of social phobia. A report of three cases. Pharmacopsychiatry 1994;27:186–8.
- American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 3rd edn., revised (DSM-III-R). Washington DC: APA; 1987.
- Montgomery SA, A– sberg MA. A new depression scale designed to be sensitive to change. Br J Psy-chiatr 1979;134:382–9.
- Guy W. Early clinical drug evaluation (ECDEU) assessment manual for psychopharmacology. Bethesda (MD): National Institute of Mental Health; 1976 Publication No.: 76–338.
- Liebowitz MR, Gorman JR, Fyer AJ. Pharma-cotherapy of social phobia: an interim report of placebo-controlled comparison of phenelzine and atenolol. J Clin Psychiatr 1988;8:252–7.
- Lipman RS. Depression scales derived from the Hopkins Symptom Checklist. In: Sartorius N, Ba TA, editors. Assessment of depression. Berlin: Springer; 1986. pp. 232–48.
- Bech P. Rating scales for psychopathology, health status and quality of life. Berlin: Springer; 1993
- Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K. The UKU side-effect rating scale. Acta Psychiatr Scand 1987;76(Suppl 334):1–100.
- Lin W, Frade P. Simultaneous quantification of eight tricyclic antidepressants in serum by high performance liquid chromatography. Ther Drug Monit 1987;9:448–55.
- Maddock RJ, Carter CS, Blacker KH, Beitman BD, Krishnan RR, Jefferson JW, et al. Relationship of past depressive episodes to symptom severity and treatment response in panic disorder with agoraphobia. J Clin Psychiatr 1993;54:88–95.
- Tiihonen J, Kuikka J, Bergstro–m K, Lepola U, Koponen H, Leinonen E. Dopamine reuptake site densities in patients with social phobia. Am J Psychiatry 1997;154:239–42.
- Agras WS. Treatment of social phobia. J Clin Psychiatr 1990;51(Suppl 10):52–5.
- Gelernter CS, Uhde TW, Cimbolic P. Cognitive-behavioral therapy and pharmacological treatments of social phobia. A controlled study. Arch Gen Psychiatr 1991;48:938–45.
- Black B, Uhde TW, Tancer ME. Fluoxetine for treatment of social phobia. J Clin Psychopharma-col 1992;12:293–5.
- van Ameringen MC, Mancini DL, Streiner DL. Fluoxetine efficacy in social phobia. J Clin Psychi-atr 1993;54:27–32.
- Davidson JRT, Miner CM, De Veaugh-Geiss J, Tupler LA, Colcet JT, Potts NLS. The brief social phobia scale: a psychometric evaluation. Psychol Med 1997;27:161–6.
- Schneier FR, Klein DF. Placebo response in anxiety disorders. Anxiety Disorders Association of